teleo-codex/entities/health/bendable-therapy.md
Teleo Agents 46ad74b00d vida: extract claims from 2026-02-18-medrxiv-oregon-psilocybin-services-mental-health-outcomes
- Source: inbox/queue/2026-02-18-medrxiv-oregon-psilocybin-services-mental-health-outcomes.md
- Domain: health
- Claims: 0, Entities: 2
- Enrichments: 3
- Extracted by: pipeline ingest (OpenRouter anthropic/claude-sonnet-4.5)

Pentagon-Agent: Vida <PIPELINE>
2026-05-11 04:25:03 +00:00

37 lines
No EOL
1.6 KiB
Markdown

# Bendable Therapy
**Type:** Psilocybin service center
**Location:** Portland, Oregon
**Status:** Operating under Oregon Measure 109
**Domain:** Psychedelic-assisted therapy
## Overview
Bendable Therapy is a psilocybin service center operating under Oregon's Measure 109 state-regulated psilocybin program. The center is notable for exceeding Oregon's minimum regulatory requirements by providing enhanced screening, multiple preparation sessions, and structured integration support.
## Research
Bendable Therapy conducted the first published outcomes study from Oregon's Measure 109 program, a prospective naturalistic study from March 2024 to April 2025. The study enrolled 91 clients with 88 completing all components, demonstrating large effect sizes for depression (d=0.90), anxiety (d=1.04), and wellbeing (d=2.14) at 30-day follow-up.
## Service Model
- Average dose: 27.8 mg Total Psilocybin Equivalents
- Session format: 56.8% individual, 43.2% group
- Integration: 80% client attendance rate
- Enhanced protocol beyond Oregon minimum requirements
## Client Demographics
The center's client base reflects significant demographic disparities:
- 87.5% white (vs. Oregon general population)
- 84.1% completed higher education
- 77.3% earning above $50K annually
- 46.6% traveling from out of state
- 64.8% with prior psilocybin experience
- Median age 43 years
## Timeline
- **2024-03** — Began prospective naturalistic outcomes study
- **2025-04** — Completed data collection for first Oregon Measure 109 outcomes study
- **2026-02-18** — Published medRxiv preprint showing large effect sizes but significant demographic disparities in access